Friedlaender, Alex, Giulio Metro, Diego Signorelli, Alessio Gili, Panagiota Economopoulou, Fausto Roila, Giuseppe Banna, et al. “Impact of Performance Status on Non-Small-Cell Lung Cancer Patients With a PD-L1 Tumour Proportion Score ≥50% Treated With Front-Line Pembrolizumab”. Acta Oncologica 59, no. 9 (September 1, 2020): 1058–1063. Accessed November 21, 2024. https://medicaljournalssweden.se/actaoncologica/article/view/24363.